The CD18 mAb 60.3 and the CD49d mAb HP1 /2 were given at the time of intraperitoneal instillation of either protease peptone or live Escherichia coli bacteria and at 12 h. Leukocyte emigration was evaluated at 4 and 24 h. PMN emigration 4 h after protease peptone instillation and injection of both mAbs was 10% of that in saline treatment. It was 15% of that in saline treatment after mAb 60.3 alone and unchanged by mAb HP1 / 2. At 24 h PMN emigration in response to protease peptone was not prevented by either CD18 or CD49d mAbs, however, when given together emigration was 10% of saline-treated animals. Mononuclear cell emigration to protease peptone was enhanced at 4 h by both CD18 and CD49d mAbs. The CD18 mAb did not augment mononuclear emigration in response to live bacteria. At 24 h, neither the CD18 nor the CD49d mAb alone blocked emigration ofmononuclear cells, but the combination of the two did. These studies demonstrate that: (a) early (4 h) PMN emigration is CD11 /CD18 dependent; (b) late (24 h) PMN emigration is CD1 1 /CD18 independent; and (c) mononuclear cells utilize the integrins CD18 and CD49d. (J.
Introduction
Phagocytes must emigrate from blood to extravascular sites as part ofthe normal host defense and repair. A variety ofinflammatory stimuli activate or up-regulate adhesion molecules on both phagocytes and endothelial cells causing them to become proadhesive (1) . This results in phagocyte adherence to endothelial cells, followed by their migration along the endothelial surface to intercellular junctions, diapedesis between endothelial cells, and migration through the interstitial space to participate in the inflammatory reaction (2) . During the initial stages the majority ofthe cells at the site of inflammation are neutrophils, but by 24-48 h mononuclear phagocytes predominate (3, 4) .
Phagocyte adherence to endothelium can occur after activation of ,S3-and ,32-integrin receptors each consisting of an a chain noncovalently linked to a f chain. The j3I subfamily functions in mononuclear leukocytes (8, 9) , lymphocytes (9) (10) (11) , eosinophil (11) (12) (13) , and basophil (13) adherence to endothelium in vitro. Its counterstructure on endothelial cells is the cytokine-induced ligand, vascular cell adhesion molecule-1 (VCAM-l) (14) .
The #2 subfamily consists of three distinct a chains designated aL (CDl la), aM (CDlIb), and ax (CDl lc) associated with the common /2 chain (CD1 8) (15) . These heterodimers are found exclusively on leukocytes and mediate primarily cell-cell adhesion. Intercellular adhesion molecule-l (ICAM-1) and ICAM-2 are endothelial ligands for CD1 la/CD 18 (16, 17) . ICAM-l is also a ligand for CDl lb/CD18 (18, 19) .
The importance of ,2-integrins in phagocyte emigration in vivo is established by the leukocyte adhesion deficiency (LAD) syndrome, the heritable deficiency ofCD 1 /CD 18. In affected patients sites ofinflammation or infection are devoid ofneutrophils although some mononuclear leukocytes and eosinophils are present (20) . Likewise, treatment of experimental animals with (mAbs to CD 11 /CD18 inhibits neutrophil emigration to sites of inflammation (21) . To Lavage consisted of gently washing the peritoneal contents with sterile saline (50 ml) containing heparin ( 100 U/ml) followed by aspiration of all available saline. Total and differential cell counts were performed on the lavage fluid to determine cell number and cell type. Animals given protease peptone were divided into four experimental groups and given the following intravenous treatment: (a) saline (n = 6 at 4 and 24 h), (b) the CD18 mAb 60.3 (2 mg/kg) alone (n = 6 at 4 and 24 h), (c) the CD49d mAb HPI /2( 1 mg/kg) alone (n = 6 at 4 h and n = 7 at 24 h), and (d) the combination of mAb 60.3 (2 mg/kg) and mAb HPI/2 (1 mg/kg) (n = 6 at 4 h and n = 5 at 24 h). Animals assigned to these groups were killed at either 4 or 24 h after instillation ofprotease peptone. All animals received mAb at time zero (2 mg/kg, CD18 or 1 mg/kg CD49d) and those killed at 24 h received a second identical injections at -12 h later. The plasma half-life of these two mAbs is > 12 h (data not shown) thus the repeat dosing was every 12 h. Animals given E. coli were treated with either saline (n = 9 at 4 h and n = 7 at 24 h) or mAb 60.3 (n = 7 at 4 h and n = 6 at 24 h) (treatment as above) and followed for 4 or 24 h. PMNs in the lavage fluid from the animals given bacteria were not different from those reported previously and the data have been combined (22) . The timing ofthe peritoneal lavage was selected in order to investigate emigration expected to be dominated by PMNs (4 h) and a second dominated by mononuclear cells (24 h FACS analysis. We examined rabbit PMNs and mononuclear leukocytes prepared from whole blood using fluorescence-activated cell sorting. Blood was drawn from two rabbits at 24 h after instilling protease peptone into the peritoneum. One animal was given two doses of mAb 60.3 and the other two doses of mAb HPl /2 as described above.
It was placed in a solution to lyse the red blood cells. After centrifugation, the supernatant was discarded and cells were again placed in a solution to lyse the remaining red blood cells. White blood cells were then washed in phosphate-buffered saline and resuspended in Hank's balanced salt solution. These white blood cells were incubated with mAb 60.3, mAb HPI /2, or a nonspecific murine IgG to evaluate surface expression of CD49d or CD18. Detection of murine mAb was performed with a goat anti-mouse-labeled antibody. Both PMNs and mononuclear leukocytes were investigated by gating on the appropriate window. Lavage cells taken at 24 h from the peritoneum of these animals were prepared by a similar technique.
Statistics. Difference between all ofthe groups was tested using the Kruskal-Wallis test for differences among means and post hoc testing using Mann-Whitney U-test with the conservative Bonferroni correction for multiple tests. The computer program StatView II was used in these computations. Differences were assumed to be statistically significant for P < 0.05. Data are presented as mean ± standard error.
Results
Circulating leukocytes. In normal rabbits mAb HPl /2 caused a slight decrease in circulating leukocytes of < 10% during the first 30 min after administration (data not shown). This was followed by a steady increase in leukocyte number over the next 24 h with mononuclear cells accounting for the majority of the increase. mAb 60.3 resulted in no acute changes in circulating leukocytes (data not shown), but did cause an increase in number of PMNs over a 24 -h period.
FACS analysis. Rabbit mononuclear cells stained positive for CD49d, and as expected the PMNs were negative. The leukocytes ofthe rabbit given mAb 60.3 were positive for presence of mAb, and addition of more mAb did not alter the plot of cell number vs. fluorescence. Likewise, the leukocytes of the rabbit given mAb HPl /2 were positive for mAb, and plot of cell number vs. fluorescence was not changed with additional mAb. These results show that mAb concentration were sufficient to saturate all of the sites on the cell surface. Lavage cells of the animal given mAb 60.3 were also saturated with mAb.
All peritoneal cells of the rabbit given mAb HPl /2 were negative for VLA-4a.
Lavage leukocytes (protease peptone-saline treatment).
The number of mononuclear leukocytes and PMNs from animals treated with saline and having protease peptone instillation into the peritoneum are shown in Fig. 1 . The baseline values were taken from identical experiments in our laboratory and reported by Mileski et al. (22) . Leukocyte accumulation was similar to that observed in other inflammatory processes (3, 4, 25) . Mononuclear leukocytes in the peritoneum 4 h after instillation of protease peptone was > 3.5 times greater than in normal rabbits (22) and continued to increase over the next 20 h to -9.5 times the 4-h value. PMNs in the peritoneum of normal rabbits was -7.9% of the lavage cells. PMN emigration was rapid over the first 4 h and exceeded the number of mononuclear leukocytes at that time but decreased over the next 20 h resulting in more mononuclear leukocytes than PMNs at 24 h.
Lavage neutrophils (protease peptone-mAb treatment). Fig. 3 . The mononuclear leukocyte population in the peritoneum was markedly and unexpectedly increased in the animals treated with mAb 60.3 at 4 h after instillation of protease peptone compared with saline-treated animals (P < 0.05). Similar results were observed in one additional animal after injection ofanother CD1 8 mAb designated MHM23 (data not shown). The mean number of mononuclear leukocytes in the animals treated with mAb HPl .2 was greater (but not significantly) than the saline-treated at 4 h. The combination of these mAbs resulted in a reduction in mononuclear cell number compared with mAb 60.3 alone at 4 h (P < 0.05). Treatment with either mAb 60.3 or mAb HPl /2 alone had little or no effect on mononuclear leukocyte emigration evaluated at 24 h compared with saline-treated animals. The combination of the two mAbs prevented much of the mononuclear leukocyte emigration into the peritoneum compared with saline or either mAb alone. However, significance was found only for mAb 60.3 vs. both mAbs and not for saline or mAb HPl /2 vs. both.
Lavage leukocytes (E. coli-mAb treatment). A graphical display of the emigration of leukocytes into the peritoneum in response to E. coli is shown in Fig. 4 . Cell number 4 h after instillation of the E. coli was significantly increased with the majority being PMNs. Treatment with mAb 60.3 resulted in a > 85% reduction in PMN emigration in response to instillation of bacteria, a result similar to that found previously (22) . The CD18 mAb caused little change in the mononuclear leukocyte emigration after instillation of bacteria compared with the 10-fold increase seen after instillation of protease peptone. The PMN emigration evaluated at 24 h following E. coil instillation was primarily CD18 independent as was the case with protease peptone instillation. Mononuclear leukocyte emigration, as expected, was greater at 24 h than at 4 h and was not significantly LAD patients (20, 26, 27) and by the ability ofCD1 lb mAbs to reduce mononuclear leukocyte accumulation in inflamed peritoneum (28) and delayed-type hypersensitivity reactions (29) . All circulating leukocytes except neutrophils also express the fB,-integrin VLA-4 (CD49d/CD29). Adherence of these cell types to cytokine-activated endothelial cells in vitro involves VLA-4 binding to VCAM-1 as well as CDl /CD 18 binding to ICAM-1 or -2 (8-13, 15, 30) . The presence of this #3-integrin on peripheral blood cell types other than neutrophils may account for the ability of mononuclear leukocytes and eosinophils but not neutrophils to traffic to sites of inflammation and immune reactions in LAD syndrome (31) . Interestingly, transendothelial migration of mononuclear leukocytes (32) and lymphocytes (33, 34) in vitro utilizes CD 11 / CD 18-ICAM-I but not VLA-4-VCAM-1. However, a VLA-4a mAb has been reported to inhibit lymphocyte emigration to sites of immune reaction (35) , the role of VLA-4 in mononuclear leukocyte emigration has not been previously examined.
In the present study we determined the effect ofCD 18 mAb and VLA-4a (CD49d) mAb given alone or in combination on neutrophil and mononuclear leukocyte emigration into inflamed peritoneum. Phagocyte accumulation was assessed at 4 and 24 h after instillation of protease peptone. As expected, in control animals neutrophil accumulation was markedly greater than mononuclear leukocyte accumulation at 4 h, whereas at 24 h mononuclear leukocytes were the predominant cell type. We also determined the effect of CD 18 and CD49d blockade on phagocyte accumulation at these two time points separately.
Administration ofCD 18 mAb largely prevented neutrophil accumulation at 4 h, consistent with previous studies (36) (37) (38) (39) (40) . The CD49d mAb which does not bind to PMNs was without effect on neutrophil emigration at 4 h. Surprisingly, mononuclear leukocyte emigration at 4 h after instillation of protease peptone was greater in all three groups tested with CD 18 or CD49d mAbs compared with saline-treated animals (although the increase was significant only in the mAb 60.3-treated group). There was a 10-fold increase with CD 18 mAb 60.3, 4-fold increase with the CD49d mAb, and a 2-fold increase with the combination. The total number of mononuclear leukocytes that accumulated by 24 h after either CD1 8 or CD49d mAb treatment alone was somewhat greater than at 4 h but not significantly greater than the saline-treated group. Thus, treatment with CD 18 or CD49d mAbs appears to represent an acceleration ofthe time course ofemigration rather than an absolute increase in the -number of emigrating cells. Notably, the enhanced emigration at 4 (42) and into the peritoneum after recruitment of macrophages (22) . The emigration into the peritoneum was shown to occur as a result of factor(s) released by macrophages. Thus, we propose that PMN emigration in the present experiments occurs in part as a result of a factor released by macrophages. The inhibition of PMN emigration produced by the combination of CD18 and CD49d mAbs is thus an indirect result of blocking mononuclear leukocyte emigration into peritoneum by inhibiting CD18 and CD49d as well as direct blockade of CD18 on PMNs.
The instillation of E. coli bacteria resulted in a similar pattern of leukocyte emigration compared with protease peptone. At 4 h, PMN emigration was strongly dependent on CD18 for emigration to occur with > 85% inhibition by mAb 60.3. This was a similar reduction to that seen with protease peptone as a stimulus; however, there was no accelerated mononuclear cell emigration at 4 h with E. coli. At 24 h PMN emigration after E. coli, like protease peptone, was not altered by CD 18 mAbs.
Administration of CD49d mAb alone resulted in a marked increase in circulating mononuclear leukocytes but not PMNs. Similar results were reported by Issekutz in the rat (35) . Of interest, administration ofCD1 8 mAbs produce a neutrophilic leukocytosis (40) . The mechanism of CD49d mAb-induced mononuclear leukocytosis is unknown but could result from inhibition of lymphocyte recirculation or a release of leukocytes from bone marrow. This speculation comes from the demonstration that VLA4-a mediates lymphocyte binding to peripheral lymph nodes high endothelial venules (43, 44) and hematopoietic cell binding to marrow stroma (45) .
Finally, although our studies demonstrate conclusively that mononuclear leukocytes utilize VLA-4 as well as CD 18 in emigration to extravascular tissue, they do not necessarily indicate that the blockade is at the level of adhesion to endothelium. VLA-4 binds to the CS-1 fragment of fibronectin as well as to endothelial VCAM-1. Conceivably, inhibition of VLA-4 binding to fibronectin in the subendothelial matrix could prevent mononuclear leukocyte accumulation in the peritoneum. Additional studies with mAbs directed to endothelial ligands ICAM-1 and VCAM-1 are necessary in order to define the counterstructures for CDl 1 /CD1 8 and CD49d/CD29.
